The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of generic competition , significantly eroding its dominance. While specific pharmaceutical companies may attempt to capitalize on related treatm